Discovery of a role of the novel hepatokine, hepassocin, in obesity

• Published in: BioFactors (Oxford) Vol. 46; no. 1; pp. 100 - 105
• Main Authors: Huang, Ru‐Lai, Li, Chung‐Hao, Du, Ye‐Fong, Cheng, Kai‐Pi, Lin, Ching‐Han, Hu, Che‐Yuan, Wu, Jin Shang, Chang, Chih‐Jen, Wu, Hung‐Tsung, Ou, Horng‐Yih
• Format: Journal Article
• Language: English
• Published: Hoboken, USA John Wiley & Sons, Inc 01.01.2020
• Subjects: diabetes; hepassocin; HOMA‐IR; obesity; overweight; HOMA-IR; hepassocin; diabetes; overweight; obesity

Obesity is a public health problem that has raised concerns worldwide and is often associated with hepatic steatosis. Hepassocin is a novel hepatokine that causes hepatic steatosis and induces insulin resistance (IR). However, the role of hepassocin in obesity remains obscure. Thus, the aim of this...